$UNH Citi analyst Ralph Giacobbe lowered the firm's price target on UnitedHealth to $339 from $346 and keeps a Buy rating on the shares. The analyst reduced 2021 and 2022 estimates to reflect the economic backdrop and lower commercial enrollment.